We are live on
!
Find out more
Pzena Investment Management Portfolio holdings
AUM
$30.8B
1-Year Est. Return
11.29%
This Fund
S&P 500
This Quarter
Est. Return
-6.71%
1 Year Est. Return
+11.29%
3 Year Est. Return
+35.84%
5 Year Est. Return
+55.56%
10 Year Est. Return
+196.8%
AUM
$28.4B
AUM Growth
-$689M
(-2.4%)
Cap. Flow
+$1.33B
Cap. Flow
% of AUM
4.68%
Top 10 Holdings %
Top 10 Hldgs %
35.45%
Holding
171
New
12
Increased
50
Reduced
85
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$660M |
| 2 |
Global Payments
GPN
|
+$467M |
| 3 |
CVS Health
CVS
|
+$462M |
| 4 |
Baxter International
BAX
|
+$237M |
| 5 |
Magna International
MGA
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitable Holdings
EQH
|
+$262M |
| 2 |
Wabtec
WAB
|
+$223M |
| 3 |
Gildan
GIL
|
+$122M |
| 4 |
American International
AIG
|
+$93.2M |
| 5 |
Wells Fargo
WFC
|
+$84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.5% |
| 2 | Healthcare | 17.76% |
| 3 | Technology | 16.54% |
| 4 | Consumer Discretionary | 11.92% |
| 5 | Consumer Staples | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cognizant
CTSH
$24.9B
| $1.27B | 4.45% |
18,609,898
+1,943,127
| +12% | +$132M |
|
|
2
Magna International
MGA
$18.7B
| $1.2B | 4.23% |
20,958,945
+2,915,596
| +16% | +$136M |
|
|
3
Baxter International
BAX
$13.5B
| $1.03B | 3.63% |
30,823,004
+6,417,584
| +26% | +$237M |
|
4
Dow Inc
DOW
$21.9B
| $1B | 3.52% |
18,865,864
+347,565
| +2% | +$19.9M |
|
5
Citigroup
C
$222B
| $972M | 3.42% |
15,317,724
-1,004,792
| -6% | -$62M |
|
6
Capital One
COF
$128B
| $960M | 3.37% |
6,932,548
-365,017
| -5% | -$51.2M |
|
|
7
Wells Fargo
WFC
$261B
| $933M | 3.28% |
15,706,472
-1,422,658
| -8% | -$84M |
|
8
Edison International
EIX
$28.2B
| $925M | 3.25% |
12,875,286
-729,794
| -5% | -$52.9M |
|
9
Charter Communications
CHTR
$17.3B
| $904M | 3.18% |
3,023,589
+175,130
| +6% | +$47.8M |
|
10
SS&C Technologies
SSNC
$18.1B
| $890M | 3.13% |
14,209,105
-309,998
| -2% | -$19.2M |
|
|
11
Humana
HUM
$43.7B
| $866M | 3.05% |
2,318,347
+1,955,375
| +539% | +$660M |
|
12
Lear
LEA
$6.54B
| $821M | 2.89% |
7,187,890
+946,109
| +15% | +$121M |
|
13
UBS Group
UBS
$173B
| $792M | 2.79% |
29,951,235
+280,696
| +0.9% | +$8.34M |
|
14
Bank of America
BAC
$435B
| $789M | 2.77% |
19,833,297
-1,632,494
| -8% | -$62.6M |
|
|
15
CVS Health
CVS
$133B
| $764M | 2.69% |
12,936,388
+7,382,931
| +133% | +$462M |
|
|
16
Equitable Holdings
EQH
$13B
| $762M | 2.68% |
18,642,684
-6,677,949
| -26% | -$262M |
|
17
Tyson Foods
TSN
$20.4B
| $714M | 2.51% |
12,489,564
+1,939,508
| +18% | +$113M |
|
18
MetLife
MET
$61.9B
| $677M | 2.38% |
9,646,066
-383,164
| -4% | -$27.4M |
|
19
NOV
NOV
$6.93B
| $669M | 2.35% |
35,175,886
+103,238
| +0.3% | +$1.93M |
|
20
Medtronic
MDT
$109B
| $654M | 2.3% |
8,307,123
+637,931
| +8% | +$52.3M |
|
|
21
Global Payments
GPN
$23B
| $621M | 2.18% |
6,423,463
+4,240,388
| +194% | +$467M |
|
22
PVH
PVH
$4B
| $595M | 2.09% |
5,623,706
+284,269
| +5% | +$32.2M |
|
23
Bristol-Myers Squibb
BMY
$133B
| $587M | 2.06% |
14,134,337
+1,840,424
| +15% | +$82.4M |
|
24
Amdocs
DOX
$5.92B
| $447M | 1.57% |
5,667,603
+1,412,826
| +33% | +$116M |
|
25
Avnet
AVT
$7.29B
| $442M | 1.55% |
8,576,821
-17,714
| -0.2% | -$907K |
|
Similar funds
Pzena Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Pzena Investment Management held 171 positions worth $28.4B, down 2.4% from $29.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Pzena Investment Management deployed $1.33B of net new capital in Q2 2024, opening 12 new positions and adding to 50 existing holdings. Its largest new stake was Kaspi.kz JSC: 867,970 shares worth $112M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Equitable Holdings, an estimated $262M trimmed.
- Pzena Investment Management's largest Q2 2024 buy was Kaspi.kz JSC: 867,970 shares worth $112M.
- Pzena Investment Management added most to Humana in Q2 2024, an estimated $660M increase.
- Pzena Investment Management's biggest Q2 2024 reduction was Equitable Holdings, cutting an estimated $262M.
- Pzena Investment Management fully exited GMS Inc in Q2 2024, selling an estimated $40.9M.
- Pzena Investment Management's ten largest holdings make up 35% of its $28.4B portfolio in Q2 2024.
- Pzena Investment Management opened 12 new positions and closed 11 in Q2 2024.
- Pzena Investment Management's portfolio value fell 2.4% quarter-over-quarter to $28.4B.
Based on Pzena Investment Management's 13F filing for Q2 2024, filed 2 Aug 2024.